MedLife acquires the majority stake in Pharmachem

MedLife Medical system announces the signing of the acquisition for the 75% majority stake of Pharmachem. It is the group’s largest acquisition this year, being, also, the first acquisition in the pharma sector.

Pharmachem has a history of drug distribution services of 16 years, being an important player, with a warehouses network in Bucharest and in the entire country. In 2019, the distribution company reached a turnover of 83.4 million RON, an increase by 30% compared to the previous year.

“As we have already announced our shareholders, we have actively kept the acquisition program and thus we sign a new transaction, this time, in the pharma area. We believe that this segment will have a very important economic recovery contribution and population’s health maintenance in the next years. Regarding the integration of Pharmachem in MedLife group, we plan two directions: first, the optimization of the drug procurement system at group level, through the own pharmacies network -PharmaLife Med, and the 12 hospitals within the group. And secondly, the development of the clickpharm.ro online pharmacy area, but also new digitization projects that will bring the right medicine closer to the patient,” said Mihai Marcu, CEO and President of MedLife Group.

Once this transaction will be completed, Pharmachem management will be led by the current shareholders, who have the right know-how to properly manage this business, but also to accelerate its growth.

The transaction is going to be analysed by the Competition Council. Once approved, MedLife group will strengthen its leading position in the private healthcare market, thus fulfilling its commitment to shareholders and partners.

For the next period, MedLife representatives intend to develop the acquisition program and expand investments.